Q-omics provides the consensus-scored MIR4472-2 profile across patient tissues and cancer cell-line models. MIR4472-2 expression is associated with patient survival in 11 of 34 cancer types, with the highest sampling consensus in LUSC. Additionally, MIR4472-2 RNA expression shows 6,177 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight LUSC, and STAD as cancer lineages where MIR4472-2 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for MIR4472-2 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes MIR4472-2 survival associations across molecular data types. MIR4472-2 RNA expression shows survival associations in the most cancer types (11). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

MIR4472-2 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	11	LUSC (75)	view →

This table ranks reproducible MIR4472-2 RNA expression–survival associations across cancer types. High MIR4472-2 expression shows unfavorable associations in LUSC, DLBC, COAD, READ and THCA, but favorable associations in STAD. The LUSC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .006). Together, the overview and detailed table identify LUSC as the clearest survival context for MIR4472-2 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Tertile	III,IV	0.402	0.705	.006	75	view →
DLBC	OS	Tertile	II,III,IV	0.172	0.949	<.001	54	view →
COAD	OS	Tertile	All	0.144	0.799	.001	45	view →
STAD	OS	Tertile	IV	1.000	0.294	.019	38	view →
READ	DFS	Tertile	III,IV	0.059	0.761	<.001	36	view →
THCA	DFS	Tertile	IV	0.270	0.832	.014	21	view →

Pink = unfavorable, green = favorable. all 11 lineages →

MIR4472-2-LUSC (OS)

Kaplan–Meier survival curve for MIR4472-2 RNA expression in LUSC: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with MIR4472-2 in patient tissues and cancer cell lines. In patient samples, MIR4472-2 shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Function (RNA)	6,177	STAD (5610)	view →
RNA	2,599	KIRP (741)	view →